Revised SPCs: Bupeaze (buprenorphine) Transdermal Patches – all strengths

SPCs revised to warn concomitant administration of buprenorphine and other serotonergic agents (such as selective serotonin re-uptake inhibitors or tricyclic antidepressants) may result in serotonin syndrome.

Source:

electronic Medicines compendium